FDA requiring drug manufacturers to pay for physicians' immediate-release opioid training — 5 insights

The FDA is requiring drug manufacturers to provide and pay for physicians' training relating to immediate-release opioids, Medscape reports.

Here's what you should know:

1. The provision is similar to what the FDA requires for extended-release formulations.

2. FDA Commissioner Scott Gottlieb, MD, estimates 90 percent of all opioid prescriptions are for immediate-release formulas.

3. Although drug manufacturers will be required to pay for and provide the training, physicians can voluntarily opt-out of it.

4. Dr. Gottlieb said the FDA is considering requiring mandatory training for all providers. Currently, only nurses and pharmacists must complete the training.

5. The American Medical Association opposes mandating the training.

More articles on quality:
Majority Whip Steve Scalise undergoes surgery at MedStar Washington Hospital Center after contracting infection
Breaking down concurrent surgeries — can a practice thrive without them?
American Society of Interventional Pain Physicians' 10 updated opioid prescribing guidelines for noncancer pain

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers